πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

6,867 results for β€œDe” Clear

  1. BULEVIRTIDE, BJT-778

    Blue Earth Diagnostics Ireland Ltd

    Chronic Hepatitis D Infection

    phase 3 small molecule active

    1 trial

  2. Bacillus Calmette Guerin and interferon alpha

    Hospital Authority, Hong Kong

    Carcinoma of Urinary Bladder, Superficial

    phase 3 small molecule completed

    1 trial

  3. Balcinrenone+Dapagliflozin, Balcinrenone+Dapagliflozin, Forxiga, Balcinrenone+Dapagliflozin, Forxiga 10 mg film-coated tablets

    AstraZeneca AB

    Chronic HF and comorbid impairment of kidney function who had a recent HF event to evaluate the effect of balcinrenone/dapagliflozin versus dapagliflozin alone on HF events and cardiovascular (CV) death

    phase 3 small molecule active

    1 trial

  4. Barley beta-glucan(3.0g)

    Hospital Authority, Hong Kong

    Overweight; Hyperlipidemia

    phase 3 other completed

    1 trial

  5. Baxdrostat, Baxdrostat Placebo

    AstraZeneca AB

    Resistant hypertension (rHTN) defined as blood pressure that remains higher than goal levels despite the use of at least 3 anti hypertensive drugs of different classes at maximum tolerated dose, including a diuretic.

    phase 3 small molecule active

    1 trial

  6. Baxdrostat, Baxdrostat Placebo, Baxdrostat

    AstraZeneca AB

    Uncontrolled hypertension (uTHN) defined as blood pressure that remains higher than goal levels despite patients being treated with 2 anti-hypertensive agents, including a diuretic. Resistant hypertension (rHTN) defined as blood pressure that remains higher than goal levels despite the use of at least 3 anti hypertensive drugs of different classes at maximum tolerated dose, including a diuretic.

    phase 3 small molecule active

    1 trial

  7. Baxdrostat, Baxdrostat, Baxdrostat Placebo

    AstraZeneca AB

    Primary Aldosteronism defined by excess aldosterone secretion

    phase 3 small molecule active

    1 trial

  8. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 3 other completed

    3 trials

  9. Behavior therapy

    United Therapeutics Europe Ltd

    Autism Spectrum Disorder

    phase 3 other active

    1 trial

  10. Behavioral Drug and HIV Risk Reduction Counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 3 other completed

    1 trial

  11. Beltavac Polymerized placebo. It is a saline solution without the allergenic extract, BELTAVAC with polymerized extract From Dermatophagoides

    Lacuna Pharma Pty Ltd

    Allergic rhinoconjunctivitis due to exposure of house dust mites

    phase 3 small molecule active

    1 trial

  12. Bempedoic Acid + Ezetimibe Fixed-Dose Combination

    Esperion Therapeutics

    Hyperlipidemias

    phase 3 other completed

    1 trial

  13. Bempegaldesleukin

    Nektar Therapeutics UK Limited

    Melanoma

    phase 3 mab terminated

    1 trial

  14. Bempegaldesleukin

    Nektar Therapeutics UK Limited

    Metastatic Head and Neck Cancer

    phase 3 small molecule terminated

    1 trial

  15. Bendamustine 100 mg Powder for concentrate for Solution for Infusion, Truxima 100 mg concentrate for solution for infusion, RoActemra 20 mg/mL concentrate for solution for infusion, PREDNISONE BIOGARAN 20 mg, scored tablet, Cyclophosphamide Injection 500 mg., Doxorubicin 2 mg/ml Solution for Injection., Truxima 500 mg concentrate for solution for infusion, Vincristine Sulfate 1 mg/ml solution for injection, Revlimid 5 mg hard capsules, Epcoritamab (GEN3013), Epcoritamab (GEN3013), Revlimid 20 mg hard capsul

    AbbVie Deutschland GmbH & Co. KG

    Follicular Lymphoma

    phase 3 small molecule active

    1 trial

  16. Bendamustine hydrochloride

    Teva Pharma GmbH

    Non-Hodgkin Lymphoma

    phase 3 small molecule completed

    1 trial

  17. Benlysta 200 mg solution for injection in pre-filled syringe., Placebo for Belimumab Solution for Injection, 200 mg/mL. The placebo for Belimumab Solution for Injection, 200 mg/mL is provided as a sterile solution for subcutaneous (SC) injection in single-use prefilled syringes.

    GlaxoSmithKline

    Lung Diseases, Interstitial

    phase 3 small molecule active

    1 trial

  18. Berotralstat, Orladeyo 150 mg hard capsules, Berotralstat, Berotralstat, Berotralstat

    Lacuna Pharma Pty Ltd

    Hereditary Angioedema (HAE)

    phase 3 small molecule active

    1 trial

  19. Betahistine dihydrochloride, BETASERC 24 mg, comprimΓ©

    Lacuna Pharma Pty Ltd

    Menière's disease

    phase 3 small molecule active

    1 trial

  20. Betamethasone Microsphere (DE-102οΌ‰ Low Dose

    Santen Oy

    Diabetic Macular Edema

    phase 3 small molecule completed

    1 trial

  21. Beyfortus 100 mg solution for injection in pre-filled syringe, Beyfortus 50 mg solution for injection in pre-filled syringe, Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)

    Fondazione Telethon ETS

    Respiratory Syncytial Virus (RSV)

    phase 3 small molecule active

    1 trial

  22. Bias retraining

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Use Disorder

    phase 3 other completed

    1 trial

  23. Bilateral Nucleus Accumbens DBS (Suzhou Sceneray)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obsessive Compulsive Disorder

    phase 3 other terminated

    1 trial

  24. Bimatoprost SR

    AbbVie Deutschland GmbH & Co. KG

    Open-angle Glaucoma, Ocular Hypertension

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources